Back

Therapeutic benefit of PKP2 restoration in arrhythmogenic cardiomyopathy

18 March 2023 (11:15 - 11:37)
Organised by: Logo
Seminar Presentation Part of: Precision medicine: gene editing - RNA therapeutics and the first steps in the clinic Basic Science Open Access HFA Winter Research Meeting on Translational Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Eva Van Rooij

Hubrecht Institute, Utrecht (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
Gene therapy approaches in large animal models of cardiomyopathy
Professor C. Kupatt (Munich, DE)
Presentation thumbnail
In vivo gene editing for ATTR cardiomyopathy - first in human trial
Professor M. Fontana (London, GB)

Access the full session

Session thumbnail
Precision medicine: gene editing - RNA therapeutics and the first steps in the clinic

The Event

Event poster

HFA Winter Research Meeting on Translational Heart Failure 2023

18 March 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Loss of nuclear envelope integrity and DNA damage in arrhythmogenic cardiomyopathy
31 August 2025
thumbnail
Congress Presentation
Plakophilin 2 haploinsufficiency linked to arrhythmogenic cardiomyopathy is associated with sodium current abnormalities and glycogen synthase kinase 3 beta activation
21 April 2018
thumbnail
Congress Presentation
Different prognosis of ARVC patients between DSG2 and PKP2 variant carriers
28 August 2022
thumbnail
Congress Session
Ventricular tachycardia (2)
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources